Skip to Content

Notice

Advisory Committees; Notice of Meetings

Document Details

Information about this document as published in the Federal Register.

Published Document

This document has been published in the Federal Register. Use the PDF linked in the document sidebar for the official electronic format.

Start Preamble

AGENCY:

Food and Drug Administration, HHS.

ACTION:

Notice.

SUMMARY:

The Food and Drug Administration (FDA) is announcing a tentative schedule of forthcoming meetings of its public advisory committees for the remainder of 2000. At the request of the Commissioner of Food and Drugs (the Commissioner), the Institute of Medicine (the IOM) conducted a study of the use of FDA's advisory committees. The IOM recommended that the agency publish an annual tentative schedule of its meetings in the Federal Register. In response to that recommendation, FDA is publishing its annual tentative scheduled meetings for the remainder of 2000.

Start Further Info

FOR FURTHER INFORMATION CONTACT:

Donna M. Combs, Committee Management Office (HFA-306), Food and Drug Administration, 5600 Fishers Lane, Rockville, MD 20857, 301-827-4820.

End Further Info End Preamble Start Supplemental Information

SUPPLEMENTARY INFORMATION:

The IOM, at the request of the Commissioner, undertook a study of the use of FDA's advisory committees. In its final report, the IOM recommended that FDA adopt a policy of publishing an advance yearly schedule of its upcoming public advisory committee meetings in the Federal Register. FDA has implemented this recommendation. A tentative schedule of forthcoming meetings will be published annually in the Federal Register. The annual publication of tentatively scheduled advisory committee meetings will provide both advisory committee members and the public with the opportunity, in advance, to schedule attendance at FDA's upcoming advisory committee meetings. The schedule is tentative and amendments to this notice will not be published in the Federal Register. FDA will, however, publish a Federal Register notice 15 days in advance of each upcoming advisory committee meeting, announcing the meeting (21 CFR 14.20).

The following list announces FDA's tentatively scheduled advisory committee meetings for the remainder of 2000:

Committee NamesDates of Meetings
OFFICE OF THE COMMISSIONER
Science Board to the Food and Drug AdministrationApril 21
CENTER FOR BIOLOGICS EVALUATION AND RESEARCH
Allergenic Products Advisory CommitteeOctober 24
Biological Response Modifiers Advisory CommitteeMarch 20-21, October 19-20
Blood Products Advisory CommitteeMarch 16-17, June 15-16, September 14-15, December 14-15
Transmissible Spongiform Encephalopathies Advisory CommitteeNovember 2-3
Vaccines and Related Biological Products Advisory CommitteeMay 11-12, July 27-28, September 21-22, November 2-3
CENTER FOR DRUG EVALUATION AND RESEARCH
Advisory Committee for Pharmaceutical ScienceApril 26, May 15-16, November 2-3
Advisory Committee for Reproductive Health DrugsMarch 28-29, April 10, May 4-5
Anesthetic and Life Support Drugs Advisory CommitteeNovember 6-7
Start Printed Page 16207
Anti-Infective Drugs Advisory CommitteeMarch 24, September 11-12
Antiviral Drugs Advisory CommitteeJuly 20-21
Arthritis Advisory CommitteeApril 11, June 8-9, September 11-12, November 9-10
Cardiovascular and Renal Drugs Advisory CommitteeMay 1-2, July 20-21, October 19-20
Dermatologic and Ophthalmic Drugs Advisory CommitteeMay 4-5
Drug Abuse Advisory CommitteeOctober 19-20
Endocrinologic and Metabolic Drugs Advisory CommitteeMay 18-19, July 13-14, October 5-6, December 7-8
Gastrointestinal Drugs Advisory CommitteeApril 12
Medical Imaging Drugs Advisory CommitteeMay 22-23, October 30-31
Nonprescription Drugs Advisory CommitteeJune 22-23, July 13-14, October 19-20, December 7-8
Oncologic Drugs Advisory CommitteeMarch 16-17, June 5-6
Peripheral and Central Nervous System Drugs Advisory CommitteeOctober 26
Pharmacy Compounding Advisory CommitteeMay 15-16
Psychopharmacologic Drugs Advisory CommitteeJune 28-29, November 2-3
Pulmonary-Allergy Drugs Advisory CommitteeNovember 6-7
CENTER FOR FOOD SAFETY AND APPLIED NUTRITION
Food Advisory CommitteeSeptember 14-15
CENTER FOR DEVICES AND RADIOLOGICAL HEALTH
Device Good Manufacturing Practice Advisory CommitteeNo meetings planned
Medical Devices Advisory Committee
Anesthesiology and Respiratory Therapy Devices PanelMay 25-26, September 7-8, November 2-3
Circulatory System Devices PanelMay 2-3, September 25-26
Clinical Chemistry and Clinical Toxicology Devices PanelMarch 24, June 29-30, September 14-15, December 14-15
Dental Products PanelApril 6-7, May 23-24, July 18-19, October 3-4
Ear, Nose, and Throat Devices PanelMay 26, June 23, July 20-21, September 22
Gastroenterology-Urology Devices PanelApril 13-14, August 31-September 1, November 30-December 1
General and Plastic Surgery Devices PanelJune 12-13, September 11-12, December 4-5
General Hospital and Personal Use Devices PanelMay 1-2, August 7-8, November 6-7
Hematology and Pathology Devices PanelJune 12, August 8, November 7
Immunology Devices PanelJune 16, September 15, December 8
Medical Devices Dispute Resolution PanelTo be determined
Microbiology Devices PanelJune 21-22, November 16-17
Molecular and Clinical Genetics PanelJune 23, September 15, December 15
Neurological Devices PanelMarch 31, May 11-12, August 17-18, November 16-17
Obstetrics-Gynecology Devices PanelApril 10-11, July 24-25, October 9-10
Ophthalmic Devices PanelMarch 17, May 11-12, July 27-28, September 21-22, November 8-9
Orthopaedic and Rehabilitation Devices PanelMarch 18, May 4-5, August 24-25, November 16-17
Radiological Devices PanelMay 15, August 14, November 6
National Mammography Quality Assurance Advisory CommitteeJuly 10, December 11
Technical Electronic Product Radiation Safety Standards CommitteeJune 21-22
CENTER FOR VETERINARY MEDICINE
Veterinary Medicine Advisory CommitteeSeptember 15
NATIONAL CENTER FOR TOXICOLOGICAL RESEARCH
Advisory Committee on Special Studies Relating to the Possible Long-Term Health Effects of Phenoxy Herbicides and ContaminantsNo meetings planned
Science Board to the National Center for Toxicological ResearchMay 1-2
Start Signature

Dated: March 17, 2000.

Linda A. Suydam,

Senior Associate Commissioner.

End Signature End Supplemental Information

[FR Doc. 00-7429 Filed 3-24-00; 8:45 am]

BILLING CODE 4160-01-F